STAK Inc. (the "Company" or "STAK") (Nasdaq: STAK), a fast-growing company specializing in the research, development ...

Sefaxersen to reduce the production of complement factor B and lower activation of the alternative complement pathway; and Ulefnersen to reduce the production of the fused in sarcoma, as well as ...

a development candidate that uses a novel in vivo gene editing approach to permanently turn off the LPA gene in the liver to reduce blood Lp(a) levels. It has a collaboration and license agreement ...

2-Year U.S. Treasury Note Continuous Contract $103.730-0.027-0.03% 5-Year U.S. Treasury Note Continuous Contract $108.383-0.063-0.06% 10-Year U.S. Treasury Note Continuous Contract $111.125-0.094 ...

IPC Indice de Precios Y Cotizaciones 56,382.00 615.42 1.10% ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...